Alnylam Pharmaceuticals
ALNY
#618
Rank
C$43.37 B
Marketcap
$335.13
Share price
-10.08%
Change (1 day)
63.34%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company